Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S23-6.

Socioeconomic consequences of ankylosing spondylitis.

Author information

  • Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, The Netherlands.


Since ankylosing spondylitis usually starts at an early age, the socioeconomic impact of the disease on the patient and on society can be important. Several studies have reported substantial work disability, but there is considerable variation among countries. While withdrawal from work is associated with an older age at diagnosis and manual jobs or a lower educational level, sick leave in those with a paying job is associated with disease activity and physical functioning. The yearly mean total (direct and productivity) costs of AS are US$6,720 per patient in the USA and Euro 9,462 per patient in Europe when the human capital approach is used to calculate the productivity costs. A cost-effectiveness study on spa-therapy in AS shows that the clinical benefits of (expensive) treatments can be reached within acceptable costs.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk